Menu Search
Equities

Abnova Taiwan Corp

4133:TAI

Abnova Taiwan Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)29.05
  • Today's Change0.150 / 0.52%
  • Shares traded31.95k
  • 1 Year change-11.03%
  • Beta--
Data delayed at least 20 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TWDIncome statement in TWDView more

Year on year Abnova Taiwan Corp's revenues fell -7.21% from 411.76m to 382.05m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 74.84m to 43.68m, a -41.64% decrease.
Gross margin47.08%
Net profit margin16.31%
Operating margin12.35%
Return on assets4.30%
Return on equity4.57%
Return on investment4.55%
More ▼

Cash flow in TWDView more

In 2023, Abnova Taiwan Corp increased its cash reserves by 15.38%, or 56.45m. The company earned 76.22m from its operations for a Cash Flow Margin of 19.95%. In addition the company generated 36.79m cash from investing, though they paid out 55.62m more in financing than they received.
Cash flow per share1.47
Price/Cash flow per share19.62
Book value per share21.39
Tangible book value per share20.35
More ▼

Balance sheet in TWDView more

Abnova Taiwan Corp has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 423.52m.
Current ratio13.40
Quick ratio7.21
Total debt/total equity0.0035
Total debt/total capital0.0035
More ▼

Growth rates in TWD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -10.00% and -41.61%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.32%
Div growth rate (5 year)3.71%
Payout ratio (TTM)74.02%
EPS growth(5 years)-1.11
EPS (TTM) vs
TTM 1 year ago		31.74
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.